Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 17:56:101612.
doi: 10.1016/j.ijcha.2025.101612. eCollection 2025 Feb.

Is nifekalant more effective than amiodarone in improving the clinical outcomes of catheter ablation in patients with persistent atrial fibrillation?

Affiliations

Is nifekalant more effective than amiodarone in improving the clinical outcomes of catheter ablation in patients with persistent atrial fibrillation?

Tingqiong Ma et al. Int J Cardiol Heart Vasc. .

Abstract

Background: Traditionally, amiodarone or electrical cardioversion was used if radiofrequency catheter ablation (RFCA) could not terminate atrial fibrillation during the procedure in patients with persistent atrial fibrillation (PeAF).

Objective: To investigate whether the nifekalant instead of amiodarone during RFCA improve procedure outcomes in patients with PeAF.

Methods: This study enrolled patients with PeAF who failed to achieve cardioversion after initial ablation at our center between January 2020 and December 2022. These patients were classified into the nifekalant (N) group and the amiodarone (A) group. And patients were followed for 1 year to evaluate long-term success rates. Subgroup analyses and the logistic regression analyses were performed.

Results: The study comprised 300 participants and included N (n = 121) and A (n = 179) groups. Following propensity score matching (PSM), 101 participants were in each group. Within the N and A groups, 57(56.44 %) and 19(18.81 %) cases successfully terminated AF, 45 (44.56 %) and 15(14.85 %) cases achieved conversion to atrial tachycardia (P < 0.001), respectively. The ventricular tachycardia was observed in only one case in the N group (P > 0.05). The follow-up results demonstrated that one-year success rates were 63.37 % and 49.50 % for the N and A groups (P < 0.05).

Conclusion: For patients with PeAF that persists after initial catheter ablation, compared to amiodarone, administration of nifekalant could convert atrial fibrillation into atrial tachycardia, following by target ablation, has the potential to improve the procedure outcomes.

Keywords: Amiodarone; Nifekalant; Persistent atrial fibrillation; Radiofrequency catheter ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

References

    1. Narayan S.M., Cain M.E., Smith J.M. Atrial fibrillation [J] Lancet (london, England) 1997;350(9082):943–950. - PubMed
    1. Mark D.B., Anstrom K.J., Sheng S., et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial [J] JAMA. 2019;321(13):1275–1285. - PMC - PubMed
    1. Packer D.L., Mark D.B., Robb R.A., et al. Effect of Catheter Ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial [J] JAMA. 2019;321(13):1261–1274. - PMC - PubMed
    1. Parameswaran R., Al-Kaisey A.M., Kalman J.M. Catheter ablation for atrial fibrillation: current indications and evolving technologies [J] Nat. Rev. Cardiol. 2021;18(3):210–225. - PubMed
    1. SCOTT P A, SILBERBAUER J, MURGATROYD F D. The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis [J]. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, 18(3): 359-67. - PubMed

LinkOut - more resources